Combivent
Formulated to target airway constriction and indicated to support effective breathing in respiratory conditions.
- Category
- Respiratory Health
- Active ingredients
- Ipratropium · Salbutamol
- Supply
- Pharmacy
- Route
- Inhalation use
- Form
- Pressurised inhalation, solution
- Strengths
- 50/20mcg
Combivent details
- Therapeutic class
- Bronchodilator
- Pharmacological class
- Beta-2 Adrenergic Agonist; Anticholinergic
- Minor side effects
- headache; nausea; cough; dry mouth
- Moderate side effects
- tachycardia; palpitations; tremor; dizziness
- Dosage forms
- Pressurised inhalation, solution
- Administration route
- Inhalation use
- Supply category
- Pharmacist only, dispensed without a prescription
- Manufacturer
- Boehringer Ingelheim
- Onset Time
- 5–15 minutes
- Duration
- 3–6 hours
- Storage instructions
- Store below 25°C, protect from frost and direct sunlight.
- Drug interactions
- Beta-blockers; Anticholinergics
- Age restrictions
- Not recommended for children.
Contraindications
hypersensitivity to anticholinergics; hypersensitivity to soya lecithin; hypertrophic obstructive cardiomyopathy
Precautions and warnings
use with caution in narrow-angle glaucoma; avoid contact with eyes; monitor for paradoxical bronchospasm
Serious side effects
anaphylaxis, requires immediate medical attention; paradoxical bronchospasm, requires immediate medical attention
Patient summary
Formulated to target airway constriction and indicated to support effective breathing in respiratory conditions.
Mechanism of action
This medication combines two agents that relax the smooth muscles of the airways. By blocking cholinergic receptors and stimulating beta-adrenergic receptors, it helps to dilate bronchial passages, facilitating easier airflow and reducing symptoms of obstructed breathing.
Pregnancy and breastfeeding
Pregnancy: Use only if indicated. Breastfeeding: Consult a physician before use as distribution into milk is possible.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Combivent
Combivent is a combination of Ipratropium and Salbutamol, commonly used to help manage Chronic Obstructive Pulmonary Disease. Supplied as an inhaler containing 50/20mcg of each active ingredient, this product is manufactured by Boehringer Ingelheim. Many patients rely on this formulation to assist with their breathing symptoms in their daily routines.
Buying Combivent online
Combivent is registered across 14 markets including the UAE, Singapore and Hong Kong, with availability also in Thailand, Malaysia and the Philippines. As one of the most ordered respiratory products in the region, patients frequently order it online to ensure a consistent supply. Generic versions containing Ipratropium and Salbutamol, often manufactured in India, provide a more affordable alternative to the original brand for expats and those living far from a major pharmacy.